| Authors: |
Al Hadidi S; Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: Samer.AlHadidi@UTSouthwestern.edu., Costello C; Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego, CA., Costa LJ; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL., Dhakal B; Division of Hematology, Medical College of Wisconsin, Milwaukee, WI., Georges P; Oncology & Infusion Therapy, York Hospital, York, ME., Gajra A; Hematology Oncology Associates of CNY, Syracuse, NY., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN., Bhargava RS; Medical Oncology and Hematology Division, Northside Hospital Cancer Institute, Athens, GA., Paner-Straseviciute A; Early Development Hematology, Johnson & Johnson, Horsham, PA., Vij R; Division of Oncology, Department of Medicine, Washington University St. Louis, MO. |
